Turing CEO: Probe makes 'mountain out of molehill' By: CNBC.com News November 04, 2015 at 16:37 PM EST The Turing Pharmaceuticals CEO says that the price increase of the drug Daraprim won't affect overall prescription cost trends in the U.S. Read More >> Related Stocks: Retrophin Inc